Members of the international Trans-Omics for Precision Medicine (TOPMed) program report the sequencing and analysis of 53,831 diverse human genomes in this week's Nature. TOPMed was founded to use whole-genome sequencing and other omics data to better understand risk factors for heart, lung, blood, and sleep disorders.